Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Galectin-1 Inhibition as a Strategy for Malignant Peripheral Nerve Sheath Tumor Treatment

Cells(2025)10.3390/cells14070515Source: DataRank Database

Galectin-1 Inhibition as a Strategy for Malignant Peripheral Nerve Sheath Tumor Treatment is a research paper published in Cells (2025). On theSindex it has a DataRank of 0. It has been cited 1 time.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access1 citations

Free full text

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (3 grants)Impact (FWCI 0.77)OA: goldTopics (56)IDs (PubMed, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (7)

Keila E. Torres ORCID,Roger Xia,Marcio H. Malogolowkin,Ssu-Wei Hsu,Ching‐Hsien Chen ORCID

Live enrichment

PubMed:40214469 OpenAlex:https://openalex.org/W4409002726

United States National Institutes of Health

Grant: R43CA271932

United States National Institutes of Health

Grant: W81XWH-22-1-0941

National Institutes of Health

Grant: 1R43CA271932-01A1

Novel small-molecule therapeutics for malignant peripheral nerve sheath tumor

FWCI

0.77

Citation Percentile

0.7%

Citation Trend

2026

goldLicense: cc-by

journalhttps://www.mdpi.com/2073-4409/14/7/515/pdf?version=1743413006

publisherhttps://www.mdpi.com/2073-4409/14/7/515/pdf?version=1743413006

publisherhttps://www.mdpi.com/2073-4409/14/7/515/pdf

journalhttps://doi.org/10.3390/cells14070515

repositoryhttps://pubmed.ncbi.nlm.nih.gov/40214469

Fields of Study

Neurofibromatosis and Schwannoma CasesGalectins and Cancer BiologySignaling Pathways in Disease03 medical and health sciences0302 clinical medicine

MeSH Terms

AnimalsHumansMice, NudeSignal TransductionProto-Oncogene Proteins p21(ras)ApoptosisNerve Sheath Neoplasmsras ProteinsXenograft Model Antitumor AssaysGalectin 1Cell Line, TumorCell ProliferationMiceEpithelial-Mesenchymal TransitionMolecular Docking Simulation

Keywords

Cancer researchGalectin-1Malignant peripheral nerve sheath tumorNerve sheath neoplasmGalectin-3SarcomaNeurofibromatosisMetastasisBiologyMedicinePathologyCancerImmunologyInternal medicineEpithelial-Mesenchymal TransitionQH573-671Galectin 1LLS30EMTMice, NudeApoptosisXenograft Model Antitumor AssaysArticleNerve Sheath NeoplasmsProto-Oncogene Proteins p21(ras)Molecular Docking SimulationMiceMPNSTCell Line, Tumorras ProteinsHumansAnimalsCytologyRASCell ProliferationSignal Transduction

Sustainable Development Goals

SDG 0: Good health and well-being